Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orchid BioSciences was a pioneer in the field of DNA testing and genetics, originally focused on high-throughput genotyping technology. The company developed the proprietary SNP-IT platform for the analysis of Single Nucleotide Polymorphisms (SNPs), which was widely used in pharmaceutical research and clinical diagnostics. Over time, the company transitioned its focus toward DNA identity services, including forensic testing and paternity verification, rebranding as Orchid Cellmark. In 2011, the company was acquired by LabCorp, integrating its specialized genetic testing capabilities into LabCorp's broader diagnostic portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orchid BioSciences.